BINEX Co., Ltd.

BINEX Co., Ltd.

053030.KQ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$203.51B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BINEX Co., Ltd.BINEX Co., Ltd.-7--18%1.30.8

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$203.51 Billion
Enterprise Value$298.19 Billion
Earnings per Share$-101
Beta0.28
Outstanding Shares31,848,000

Return

Return on Equity-18.18%ROE
Return on Assets-9.38%
Return on Invested Capital-10.38%

Valuation & Multiples

P/E Ratio-6.96P/E Ratio
PEG0.6PEG
Price to Sales1.29Price to Sales
Price to Book Ratio1.26Price to Book Ratio
Enterprise Value to Revenue1.9
Enterprise Value to EBIT-12.71
Enterprise Value to Net Income-11
Total Debt to Enterprise0.43
Debt to Equity0.8Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 13, 2026
EPS
$118.09
Est. $115.73
Revenue Estimate
$53.00 B
Consensus analyst estimate

Next Earnings Call

Expected Date
March 12, 2027
EPS Estimate
$70.28
Consensus analyst estimate
Revenue Estimate
$44.70 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About BINEX Co., Ltd.

553 employees
CEO: Won-Seok Kim

BINEX Co., Ltd. operates as a pharmaceutical enterprise based in South Korea. The company provides an extensive array of medicinal products, encompassing bisroot items, gastrointestinal treatments (including antispasmodics and antiulcera...